Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026

2026-03-26 - 11:10

NEW YORK -- Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced additional details for its Investor & Analyst Day in New York on April 22, 2026. Read More